Ticker archive · $NEO

$NEO Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $NEO — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$NEO

$NEO – NeoGenomics Reports Q3 Revenue Growth of 11% to $209M, Raises FY26 Guidance

NEOGENOMICS INC

2026-10-28 00:00:00 UTC · SEC_8K · All $NEO

?? Positive AI Sentiment (+6.5 / 10)

Q3 revenue reached $209M (+11% YoY) with Clinical Services up 13% and NGS up 29%
Net loss narrowed significantly to $(7.5)M or $(0.06)/share vs. $(27.1)M or $(0.21)/share YoY
Raised FY26 revenue guidance to $807M–$809M and adjusted EBITDA to ~$60M

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?